TTrialPathMatch Me to Trials
← Back to trials
RecruitingCardiovascular DiseasesObesity

The Weight of Cardiovascular Disease

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to evaluate the impact of a cardiometabolic clinic on percent body weight loss, body mass index (BMI), and visceral adiposity distribution in obese adults with cardiovascular disease (CVD) at 12 months.

Sponsor: Mayo Clinic

You may qualify if…

  • ✓ BMI ≥30 kg/m2
  • ✓ At least one of the following CVD: atrial fibrillation (AF), coronary artery disease (CAD), HFpEF (heart failure with preserved ejection fraction), HFrEF (heart failure with reduced ejection fraction), ACHD (adult congenital heart disease), or valvular heart disease
  • ✓ Patients evaluated in the Cardiometabolic clinic
  • ✓ Willingness to complete questionnaires/surveys
  • ✓ Ability to complete monthly self-assessments at home

You may not qualify if…

  • ✕ BMI \<30 kg/m2
  • ✕ Pregnancy or lactating women
  • ✕ Hemodynamically unstable CVD
  • ✕ Active malignancy
  • ✕ Autoimmune or systemic inflammatory diseases
  • ✕ Severe renal or hepatic failure
  • ✕ Being considered unsafe to participate as determined by the study physician
  • ✕ Taking medications affecting weight or energy intake/energy expenditure in the last 6 months, including weight loss medications, antipsychotic medications, or other medications as determined by the study NP or physician

Where it's recruiting

Minnesota

Rochester

Source: ClinicalTrials.gov · NCT06053645 · last updated 2025-10-20

The Weight of Cardiovascular Disease · TrialPath